Abstract
Demineralised bone matrix (DBM) is produced by grinding cortical bone into a powder, sieving the powder to obtain a desired size range and then demineralising the powder using acid. Protocols for the production of DBM powder have been published since 1965 and the powder can be used in lyophilised form or it can be mixed with a carrier to produce a paste or putty. The powder is generally produced from cortical bone which has been processed to remove blood, bone marrow and bone marrow components, including fat. Removal of fat is accomplished by incorporating incubation in an organic solvent, often chloroform, chloroform/methanol or acetone. The use of organic solvents in a clean room environment in a human tissue bank is problematic and involves operator exposure and the potential for the solvent to be trapped in air filters or recirculated throughout the clean room suite. Consequently, in this study, we have developed a cortical bone washing step which removes fat/lipid without the use of an organic solvent. Bone was prepared from six femoral shafts from three donors by dissecting soft tissue and bisecting the shaft, the shafts were then cut into ~9–10 cm lengths. These struts were then taken through a series of hot water washes at 56–59 °C, centrifugation and decontamination steps. Washed cortical struts were then lyophilised before being ground with a compressed air milling machine. The ground bone was sieved, demineralised, freeze-dried and terminally sterilised with a target dose of 25 kGy gamma irradiation. The DBM powder was evaluated for residual calcium content, in vitro cytotoxicity and osteoinductivity by implantation into the muscle of an athymic mouse. Data indicated that in addition to removing in excess of 97 % DNA and extractable soluble protein, the washing protocol reduced lipid 10,000-fold. The processed bone was easily ground without clogging the grinder; the sterilised DBM powder was not cytotoxic but was osteoinductive in the animal model. Therefore, we have developed a method of producing osteoinductive DBM without the need to use organic solvents.
Similar content being viewed by others
References
Agarwal R, Williams K, Urnscheid CA, Welch WC (2009) Osteoinductive bone graft substitutes for lumbar fusion: a systematic review. J Neurosurg Spine 11:729–740
Bethesda MD (2006) American association of tissue banks. Standards for tissue banking. 11th ed. American Association of Tissue Banks, USA
Bomback DA, Grauer JN, Lugo R, Troiano N, Patel T, Friedlaender GE (2004) Comparison of posterolateral lumbar fusion rates of Grafton Putty and OP-1 Putty in an athymic rat model. Spine 29(15):1612–1617
Bormann N, Pruss A, Schmidmaier G, Wildemann B (2010) In vitro testing of the osteoinductive potential of different bony allograft preparations. Arch Orthop Trauma Surg 130:143–149
Dumitrescu AL (2011) Bone grafts and bone graft substitutes in periodontal therapy. Chemicals in surgical periodontal therapy. Springer, Berlin, pp 73–144
Eagle MJ, Man J, Rooney P, Hogg P, Kearney JN (2017) Assessment of an improved bone washing protocol for deceased donor human bone. Cell Tissue Bank, E-pub ahead of print, April 2014
Gruskin E, Doll BA, Futrell FW, Schmitz JP, Hollinger JO (2012) Demineralized bone matrix in bone repair: history and use. Adv Drug Deliv Rev 64(12):1063–1077
Han B, Tang B, Nimni ME (2003) Quantitative and sensitive in vitro assay for osteoinductive activity of demineralised bone matrix. J Orthop Res 21:648–654
Hidaka C, Cunningham MF, Rodeo SA, Maher SA, Zhu W (2006) Modern biologics use in orthopaedic surgery. Curr Opin Rheum 18:74–79
Honsawek S, Powers RM, Wolfinbarger L (2005) Extractable bone morphogenetic protein and correlation with induced new bone formation in an in vitro assay in the athymic mouse model. Cell Tissue Bank 6:13–23
Katz JM, Nataraj C, Jaw R, Deigl E, Bursac P (2009) Demineralised bone matrix as an osteoinductive biomaterial and in vitro predictors of its biological potential. J Biomed Mater Res B Appl Biomater 89:127–134
Lane JM (2005) Bone morphogenetic proteins: science and studies. J Orthop Trauma 19:S17–S22
Mulliken JB, Glowaki J, Kaban LB, Folkman J, Murray JE (1981) Use of demineralised allogeneic bone implants for the correction of maxillocraniofacial deformities. Ann Surg 194:366–372
Pietrzak SW, Ali SN, Chitturi D, Jacob M, Woodell-May JE (2011) BMP depletion occurs during prolonged acid demineralization of bone: characterization and implications for graft preparation. Cell Tissue Bank 12(2):81
Qiu QQ, Connor J (2008) Effects of γ-irradiation, storage and hydration on osteoinductivity of DBM and DBM/AM composite. J Biomed Res Part A 87A(2):373–379
Reddi AH, Huggins C (1972) Biochemical sequences in the transformation of normal fibroblasts in adolescent rats. Proc Natl Acad Sci 69(6):1601–1605
Rosenthal R, Folkman J, Glowacki J (1999) Demineralized bone implants for non-union fractures, bone cysts, and fibrous lesions. Clin Orthop 364:61–69
Traianedes K, Russell JL, Edwards JT, Stubbs HA, Shanahan IR, Knaack D (2004) Donor age and gender effects on osteoinductivity of demineralized bone matrix. J Biomed Mater Res B Appl Biomater 70(1):21–29
Urist MR (1965) Bone formation by autoinduction. Science 150:893–899
Wildemann B, Kadow-Romacker A, Haas NP, Schmidmaier G (2007) Quantification of various growth factors in different demineralized bone matrix preparations. J Biomed Mater Res Part A 81(2):437–442
Wolfinbarger L, Eisenlohr LM, Ruth K (2008) Demineralized bone matrix: maximising new bone formation for successful bone implantation. Orthopedic biology and medicine. Musculoskeletal tissue regeneration, biological materials and methods 6: 93–117. Humana Press
Zhang M, Powers RM Jr, Wolfinbarger L Jr (1997) Effect(s) of the demineralization process on the osteoinductivity of demineralized bone matrix. J Periodontol 68:1085
Acknowledgments
We acknowledge support of this work from the NHSBT. We would also like to thank Professor Lloyd Wolfinbarger for his help and technical advice.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Eagle, M.J., Rooney, P. & Kearney, J.N. Production of an osteoinductive demineralised bone matrix powder without the use of organic solvents. Cell Tissue Bank 16, 433–441 (2015). https://doi.org/10.1007/s10561-014-9487-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10561-014-9487-0